Related references
Note: Only part of the references are listed.Unraveling Triple-Negative Breast Cancer Tumor Microenvironment Heterogeneity: Towards an Optimized Treatment Approach
Yacine Bareche et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Molecular subtypes and precision treatment of triple-negative breast cancer
Shen Zhao et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
miR-27a-3p regulates proliferation and apoptosis of colon cancer cells by potentially targeting BTG1
Chang Su et al.
ONCOLOGY LETTERS (2019)
Exploring specific prognostic biomarkers in triple-negative breast cancer
Chang Bao et al.
CELL DEATH & DISEASE (2019)
MicroRNA-210 expression during childbirth and postpartum as a potential biomarker of acute fetal hypoxia
Barbara Vonkova et al.
BIOMEDICAL PAPERS-OLOMOUC (2019)
Identification of dysregulated miRNAs in triple negative breast cancer: A meta-analysis approach
Leimarembi Devi Naorem et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML
Lina Benajiba et al.
LEUKEMIA (2019)
miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer
Hong Jia et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
Alice Lee et al.
CANCER TREATMENT REVIEWS (2018)
Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
Nithya Krishnamurthy et al.
CANCER TREATMENT REVIEWS (2018)
Chibby suppresses aerobic glycolysis and proliferation of nasopharyngeal carcinoma via the Wnt/β-catenin-Lin28/let7-PDK1 cascade
Cheng-fu Cai et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Therapeutic landscape in mutational triple negative breast cancer
Yaqin Shi et al.
MOLECULAR CANCER (2018)
Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3 beta and F-box and WD repeat domain-containing 7
Ji Hoon Jung et al.
ONCOGENE (2018)
Atypical regulators of Wnt/β-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma
Jianxiang Chen et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2017)
Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways
Jingkun Zhao et al.
MOLECULAR CANCER (2017)
Dysregulated miR-27a-3p promotes nasopharyngeal carcinoma cell proliferation and migration by targeting Mapk10
Lihua Li et al.
ONCOLOGY REPORTS (2017)
TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition
Sai-Lan Liu et al.
CANCER LETTERS (2017)
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Roel Nusse et al.
CELL (2017)
Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment
Valery Vilchez et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
GSK-3α Is a Novel Target of CREB and CREB-GSK-3α Signaling Participates in Cell Viability in Lung Cancer
Sin-Aye Park et al.
PLOS ONE (2016)
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Eleonore Beurel et al.
PHARMACOLOGY & THERAPEUTICS (2015)
The Wnt/β-catenin pathway in ovarian cancer: A review
Rebecca C. Arend et al.
GYNECOLOGIC ONCOLOGY (2013)
MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs
Achim Aigner
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Wnt Signaling Requires Sequestration of Glycogen Synthase Kinase 3 inside Multivesicular Endosomes
Vincent F. Taelman et al.
CELL (2010)
Identification and regulation of glycogen synthase kinase-3 during bovine embryo development
I. M. Aparicio et al.
REPRODUCTION (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Share Paper
